why choose us

First received: January 24, 2023

Clinical Trial: Study of AMDX-2011P in Subjects With CAA

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Cerebral Amyloid Angiopathy

Study Type: INTERVENTIONAL


Official Title: Open Label, Blinded Endpoint Assessment Study of AMDX-2011P as a Retinal Tracer in Subjects With Cerebral Amyloid Angiopathy (CAA)

Brief Summary: The purpose of this research study is to assess safety and tolerability of a single intravenous (given through a vein) dose of the investigational retinal tracer AMDX-2011P in patients with cerebral amyloid angiopathy (CAA).

Read more